Compare HALO & EPAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HALO | EPAM |
|---|---|---|
| Founded | 1998 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 11.2B |
| IPO Year | N/A | 2012 |
| Metric | HALO | EPAM |
|---|---|---|
| Price | $67.12 | $209.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 13 |
| Target Price | $73.33 | ★ $211.54 |
| AVG Volume (30 Days) | ★ 2.5M | 845.8K |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 56.68 | N/A |
| EPS | 4.74 | ★ 6.55 |
| Revenue | $1,242,852,000.00 | ★ $5,297,859,000.00 |
| Revenue This Year | $34.83 | $17.39 |
| Revenue Next Year | $24.84 | $7.03 |
| P/E Ratio | ★ $13.75 | $31.60 |
| Revenue Growth | ★ 31.19 | 14.26 |
| 52 Week Low | $46.26 | $138.15 |
| 52 Week High | $79.50 | $269.00 |
| Indicator | HALO | EPAM |
|---|---|---|
| Relative Strength Index (RSI) | 54.13 | 69.15 |
| Support Level | $61.23 | $200.97 |
| Resistance Level | $66.60 | $214.43 |
| Average True Range (ATR) | 2.03 | 6.27 |
| MACD | 0.28 | -0.69 |
| Stochastic Oscillator | 81.90 | 76.68 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
EPAM Systems is a global IT services firm with a focus on platform engineering, software development, and consulting services. The company used to host large engineer bases in Ukraine, Belarus, and Russia, but it now delivers from various locations across different continents. EPAM's largest market is North America, which represents approximately 60% of revenue.